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ABSTRACT 
 
KRYSTAL REYES VIRUET: Exploring the Relationships among the Placental and 
Umbilical Microbiomes, the Oral Microbiota, and Adverse Pregnancy Outcomes 
(Under the direction of Flavia Teles, Steven Offenbacher, and Andrea Azcarate-Peril) 
 
 Aims: To compare the microbiomes of placenta and umbilicus samples from 44 women 
presenting periodontal diseases who experienced full term (FTB, n=22) and preterm births (PTB; 
<35 weeks, n=22), as well as, the level of maternal subgingival periodontal species in each group 
pre and post-partum. Materials and methods: Clinical and demographic data, subgingival plaque 
samples, as well as, placenta and umbilical cord tissues samples were obtained. The microbial 
content of the tissue samples were analyzed using 16rRNA sequencing, while subgingival 
biofilm samples were analyzed using checkerboard DNA-DNA hybridization method. Results: 
Most abundant phylum in both placenta and umbilicus samples was Firmicutes. Most abundant 
genera in both placenta and umbilicus samples was Veillonella. Some of the most common 
species detected were Neisseria elongata, Pyramidobacter piscolens, and Gemella morbillorum. 
Conclusion: PTB and FTB exhibit distinct umbilical microbiomes. PTB samples are more 
heavily colonized by oral pathogenic taxa, whereas FTB specimens had higher levels of 
commensal organisms. 
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CHAPTER 1: ASSOCIATION BETWEEN PERIODONTAL DISEASE AND 
ADVERSE PREGNANCY OUTCOMES 
 
Introduction 
WHO defines preterm birth as babies born alive before 37 weeks of pregnancy are 
completed, with subcategories moderate-late preterm (32 to < 37 weeks), very preterm (28 to 
<32 weeks), and extremely preterm (<28 weeks). Worldwide an estimated 11.1% of all live 
births in 2010 were born preterm (14.9 million babies born before 37 weeks of gestation), with 
preterm birth rates increasing in most countries with reliable trend data.   About 84% of preterm 
births occur after 32 weeks of gestation. Direct complications of preterm birth account for one 
million deaths each year, and preterm birth is a risk factor in over 50% of all neonatal deaths. 9 
Each year, preterm birth affects almost 500,000 infants born in the U.S. In an average 
week, over 8000 infants are born prematurely at less than 37 weeks’ gestation. Blencowe and 
colleagues ranked the U.S. as the sixth country with the greatest number of preterm births in the 
year 201010 . The effects of preterm birth amongst some survivors may continue throughout life, 
impairing neuro-developmental functioning through increasing the risk of cerebral palsy, 
learning impairment and visual disorders and affecting long-term physical health with a higher 
risk of non-communicable disease.55  Ultimately, the effects of prematurity are far-reaching: 
besides representing a significant struggle for the affected individuals and their families they also 
represent a challenge for the health care system and for the society as a whole. 
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Pathogenesis & Risk Factors of Pre-term Birth 
Preterm births can be classified into two main categories: spontaneous births or provider-
initiated preterm birth. Spontaneous preterm births can be further subdivided into preterm lab 
with intact membranes or preterm premature rupture of membranes (PPROM). Provider-initiated 
preterm birth can be due to maternal or fetal indications. In these cases, labor can be induced or 
infant can be delivered via caesarian section. 24 
Spontaneous preterm labor can be initiated by different mechanisms, which include 
immunologically mediated processes, infection and inflammation, uterine overdistension, utero-
placental ischemia or hemorrhage, stress, among others. 56 Multiple maternal and fetal  features 
have been linked to preterm birth, among these are pregnancy history, current pregnancy 
characteristics, maternal demographic characteristics,  infection, uterine contractions and cervical 
length, nutritional status, psychological characteristics, adverse behaviors, and biological and 
genetic markers. 25  
Maternal race seems to influence the risk for preterm birth. In the US, preterm birth rates 
in black Americans range from 16-18%, while in white Americans rates range from 5-9%.  Black 
mothers are three to four times more likely to have very early preterm birth than women from 
other races.21, 23 Low educational and socioeconomic status, as well as, low and high maternal 
age are among other maternal demographic features linked to preterm births.24  
Short inter-pregnancy interval increases the risk for preterm birth, with intervals of less 
than 6 months increasing the risk by more than a two-fold60. Maternal nutritional status has been 
associated to increased pre-term risk. Women with low pre-pregnancy BMI have an increased 
risk for spontaneous preterm birth.30 Obese mothers have a higher risk for babies with congenital 
anomalies, as well as, the development of gestational diabetes and pre-eclampsia.23 
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Women with previous preterm births have a 2.5 fold increased risk in the following 
pregnancy; the risk being inversely proportional to gestational age of previous pregnancy.37 
Multiple gestations have 10 times increased risk of preterm birth than single gestation, 
approximately 60% of twins are born prematurely.11, 24 Placenta previa is another condition that 
has been significantly associated with increased risk for preterm delivery and postpartum 
complications71. Certain medical conditions can lead to maternal complications which in turn can 
lead to increased risk of preterm birth, these include: diabetes, hypertension, asthma, and thyroid 
disorders. 24 Mothers suffering from depression have a <2-fold preterm birth risk.31, 50 
Other risk factors are severe psychological stress and excessive physical work. 39,67 One 
of the proposed mechanisms for the role of stress in preterm births seems to be related to 
endocrine and inflammatory/immune responses coordinated by placental corticotropin releasing 
hormone.67 High levels of C-reactive protein, a known inflammatory marker, seem to be 
associated with preterm birth.24, 52  
Lifestyle habits such as smoking and alcohol use during pregnancy have been associated 
with increased PTB. Studies have associated smoking with multiple pregnancy complications 
such as fetal growth restriction, stillbirth, placental abruption, spontaneous abortions, ectopic 
pregnancies, placenta previa, and PTB.15 Smoking relative risk of PTB ranges from 1.2-1.6 and 
the association seems to be stronger for very preterm births (<32 weeks of gestation).15, 63 
The relative risk for preterm birth in mothers consuming alcohol during the pregnancy 
seems to be dose-dependent. Women who consumed four to six drinks per week during 
pregnancy had relative risk of 1.15 (95% confidence interval: 0.84-1.57) and those who 
consumed seven or more drinks per week had a relative risk of 1.77 (95% confidence interval: 
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0.94, 3.31), however, women consuming three drinks per week or less did not appeared to have 
an increased risk of PTB.2  
The pathogenesis of preterm birth while complex, it appears to be driven by microbial 
colonization and invasion.26 Studies have suggested that intrauterine infection could be the cause 
of 25-40% of preterm births. Vaginal microorganisms have been shown to reach the cervix, 
chorioamnion, placenta, or amniotic fluid and trigger early labor via pro-inflammatory 
pathways56,61. Four major routes have been proposed to describe microbial invasion of the 
uterine cavity: ascending from the vagina and cervix, hematogenous dissemination through the 
placenta, retrograde through the fallopian tubes, and introduction during invasive procedures; 
with the ascending pathway being the most common route.24  
A review by Goldenberg, describes a mechanism by which infection can lead to PTB. In 
these mechanism, microbial invasion and colonization of the choriodecidual space activates 
maternal and fetal membranes to release exotoxins, endotoxins, and cytokines. The release of 
these inflammatory mediators promotes production and secretion of prostaglandins, 
metalloproteinases, as well as, chemotaxis and activation of neutrophils.  Spontaneous preterm 
birth is then initiated by prostaglandin mediated uterine contraction and metalloproteases 
induced membrane rupture. Fetal infection could be another pathway leading to preterm birth by 
increasing cortisol production, which in turn stimulates release of  prostaglandins.24 
In the presence of intrauterine infection, the levels of multiple inflammatory mediators 
have been found to be altered in the amniotic fluid, cervix, and serum. Mothers with symptoms 
of preterm labor show higher concentrations of G-CSF, TNF- alpha, IL-1, IL-6, IL-8, C-reactive 
protein, & fetal fibronectin, while asymptomatic mothers with intrauterine infection have shown 
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elevated levels of G-CSF, IL-6, fetal fibronectin, IL-8, and ferritin in routine screenings prior to 
the onset of preterm labor.22,24,40 
Previously, it was believed the placenta was a sterile environment in the absence of 
intrauterine infection.68 However, recent studies have demonstrated that the placenta has a 
microbiome, even in uneventful healthy pregnancies. In a case report of a woman presenting 
with spontaneous preterm labor and chorioamnionitis at 28 weeks of gestation, a microbial 
biofilm was identified in the amniotic fluid sludge.56 Intra-amniotic microbial infections studied 
using culture and 16S rRNA-based culture-independent methods have demonstrated presence of 
Fusobacterium nucleatum, Leptotrichia (Sneathia) spp., Bergeyella sp., Peptostreptococcus sp., 
Bacteroides spp., and a species of the order Clostridiales.29  
In a study were placenta samples were collected from both vaginal and cesarean 
deliveries, DNA of intestinal bacteria Bifidobacterium spp. and Lactobacillus rhamnosus were 
identified in more than 90% of samples. However, when attempting to detect any viable cells by 
cultivation they were not able to detect Bifidobacteria or L. rhamnosus.58 Gram-positive and 
negative intracellular bacteria have been identified in placental basal plates, with up to 54% of 
spontaneous preterm deliveries <28 weeks and 26% of term spontaneous deliveries (p=0.2) 
showing evidence of intracellular bacteria in the placental basal plates.61 
Aagaard and colleagues demonstrated that the placenta has its own microbiome even in 
uneventful pregnancies and that this composition was more similar to the human oral 
microbiome than to that of any other body site. Further, the authors reported an association 
between the placental microbiome composition and APOs.1 However, a study by Laude and 
colleagues, challenge these results by arguing that due to the low bacterial biomass of placenta 
samples, some or all of the bacterial DNA could be derived from contamination. Authors 
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quantified total 16sRNA gene copies using PCR and found they could not distinguish between 
communities from placental samples and contamination controls. 
Studies have sought differences in the placental microbiomes of PTB in mothers 
suffering from different medical conditions or pregnancy complications such as pre-eclampsia, 
gestational weight gain, and intramniotic infection. In a cross-sectional study evaluating 
placental microbiome in PTB, subjects with chorioamnionitis showed high abundance of 
urogenital and oral commensal bacteria54. A study comparing the microbiome of placental 
tissues of mothers with pre-eclampsia with that normotensive mothers found that 12.7% of 
placental tissue from women with pre-eclampsia were PCR-positive, while all samples from 
control women were PCR-negative. When the PCR-positive samples were analyzed using next-
generation sequencing, the authors were able to identify multiple organisms commonly 
associated with gastrointestinal infections, respiratory infections, and periodontitis3. Another 
study investigating PTB placental microbiome found no significant alterations in the placental 
microbiome in the presence of maternal obesity, however, excess maternal gestational weight 
gain was associated with an altered microbiome.4  
Doyle and colleagues compared the microbiome of placental membranes of very preterm 
and term deliveries. Using 16S rDNA sequencing, they were able to identified one family 
(Enterobacteriaceae) and six genera (Fusobacterium, Streptococcus, Mycoplasma, Aerococcus, 
Gardnerella and Ureaplasma) that were present in greater relative abundances in PT samples or 
absent in term deliveries.18 Zheng and colleagues, investigated whether the placental microbiome 
varies with low birth weight in full-term infants and found significant variations in the 
composition of placental microbiota between LBW and NBW infants at phylum and genus 
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levels. Authors concluded that in fact the placental microbiome varies in association with low 
birth weight in full-term infants.70  
Role  of Periodontal Disease on Pathogenic Mechanisms of Adverse Pregnancy Outcomes 
Oral microorganisms have been postulated to contribute to preterm birth. 35,41,43,47,66 In 
fact, periodontitis, a common oral disease of bacterial etiology and potent inflammatory 
component is strongly associated with pre-term birth. Further, levels of periodontal pathogens, 
such as Porphyromonas gingivalis and Tannerella forsythia have been detected in significantly 
higher levels in subgingival biofilm samples of mothers who delivered preterm babies.34 In 
addition, those pathogens have also been detected more commonly in the amniotic fluid and 
subgingival plaque samples of patients who gave birth to preterm neonates.19   
Several animal studies have evaluated the effects of periodontal pathogens on adverse 
pregnancy outcomes (APOs). In an animal study by Collins and colleagues, the effects of LPS 
from oral microorganisms on golden hamster pregnancy outcomes were investigated. Authors 
found that exposure to Escherichia coli LPS and Porphyromonas gingivalis LPS induced 
harmful effects on the developing fetus causing significant decreases in fetal weight, therefore, 
demonstrating that oral bacteria can cause adverse pregnancy outcomes16. In a similar animal 
study by the same group of researchers, the effects of P. gingivalis infection on the production of 
inflammatory mediators and pregnancy outcomes in golden hamsters were evaluated. P. 
gingivalis infection was found to significantly increase the levels of PGE2 and TNF-α and it was 
also found to induce adverse pregnancy outcomes including decreased fetal weight, as well as, 
increased embryolethality and fetal resorption.17 
Evidence of  hematogenous transmission of oral bacteria to placenta was shown in an 
animal study were F. nucleatum was intravenously injected into pregnant mice which resulted in 
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premature delivery, stillbirths, and non-sustained live births28 . P. gingivalis has also 
demonstrated ability to invade maternal and fetal tissues in a rodent model, resulting in 
chorioamnionitis and placentitis.8  
Offenbacher and colleagues challenged pregnant mice with Campylobacter rectus and 
found that this periodontal pathogen is able to induce placental architectural changes and 
inflammation, increase fetal brain expression of IFN-ϒ by 2.8 fold, and pup lethality by 3.9 
fold.49 C. rectus infection has also been found to increase fetal resorption and fetal growth 
restriction in the mouse model.69  C. rectus has also been shown to down-regulate placental 
expression of critical growth and developmental related genes leading to fetal growth 
restriction.12 
Fardini and colleagues employed a pregnant murine model to identified oral microbial 
species that are able to translocate to the placenta, hematogenously by injecting pooled saliva 
and pooled subgingival plaques samples into pregnant mice. Authors found that majority of the 
mice developed mixed infections with two or more different bacterial species present. These 
mice were preferentially infected by Neisseria spp. (in eight mice); Streptococcus spp. (in seven 
mice); Aggregatibacter segnis, Leptotrichia spp., and Selenomonas spp. (each in three mice); and 
Fusobacterium nucleatum and Eikenella corrodens, however, a total of 16 different 
genera/species were identified in the murine placentas20. This study was able to prove that oral 
microorganisms are able to disseminate in the blood and infect distant sites such as the placenta 
and fetus. 
Toll-like receptors have been suggested to have a role in pregnancy maintenance, 
placental immune protection, and initiation of delivery51. In pregnant mice infected with C. 
rectus, TLR4 mRNA expression was found to be elevated and microscopic analysis showed 
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evidence of increased immunofluorescence of TLR4 in trophoblasts in the placental labyrinth 
layer5. These findings suggest a possible mechanism of how periodontal pathogens are able to 
invade and colonize the placenta. 
Several human studies have shown evidence of oral microorganisms translocation to the 
intrauterine cavity. Streptococcus spp. and F. nucleatum have been identified in the amniotic 
fluid and a significant association was found between detection of bacterial DNA and adverse 
pregnancy outcomes in previous pregnancies7. Periodontal pathogens such as P. gingivalis, C. 
rectus, T. forsythia, and F. nucleatum have been detected in the amniotic fluid of mother’s with 
subgingival plaque samples positive for such pathogens.19,33 F. nucleatum has been detected in 
chorionic tissues of high-risk pregnant women, but not in tissues of normal pregnant women. 
Authors found that F. nucleatum is capable of inducing elevated production of IL-6 and CRH 
production in chorion-derived cells.64 In a case report of a term stillbirth, F. nucleatum was 
shown to translocate hematogenously to the placenta and fetus, in a mother whose subgingival 
plaque was positive for this microorganism.27 
Cahill and colleagues, evaluated samples of fetal membrane from preterm neonates and 
were able to detect Mycoplasma hominis, Pasturella multocida, Pseudomonas PH1, 
Fusobacterium nucleatum, E. coli. and Prevotella bivia. F. nucleatum was the most common 
organism identified and was shown to be linked to fetal membrane rupture and preterm 
delivery.14   
P. gingivalis antigens have been detected in placental tissues of mothers presenting with 
chorioamnionitis using immunocytochemistry.32 Vanterpool and colleagues, compared the 
presence and location of P.g. in placental and umbilical cord samples from PTB (25-32 weeks of 
gestation) and TB using immunofluorescent histology. Authors were able to detect P. gingivalis 
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in 51% of placentas and 41% of umbilical cord samples in the PTB group. When evaluating 
placental tissues, P. gingivalis was found to be significantly associated with shorter gestational 
lengths and C-section delivery but not with histological presence of chorioamnionitis or 
preeclampsia. However, P. gingivalis was significantly associated with preeclampsia when found 
in umbilical cord samples. In this study, the term group only showed presence of P. gingivalis in 
6% of placentas, however, it was not able to be detected in any of the umbilical term samples. Pg 
was only detected within villous mesenchyme of the placenta in samples of PT group, while 
presence of P. gingivalis in syncytiotrophoblasts was found in both PT and term groups. This 
study was able to establish an association between the presence and location of P. gingivalis in 
placental and umbilical tissues and APOs.65 Furthermore, periodontal pathogens have been found 
in high numbers in plaque and placentas of mothers presenting with preeclampsia, suggesting a 
possible role of these microorganisms in the pathogenesis of this disease.6,62 
Several human studies have investigated the association between periodontal disease and 
increased risk of PTB. In the 1990’s, a case-control study by Offenbacher and colleagues showed 
that periodontal disease is a statistically significant risk factor for preterm low birth weight 
(PLBW) with odd ratios of 7.9  for all PLBW cases.41 A 5-year prospective study in pregnant 
women periodontal disease incidence and progression was found to be significantly associated 
with low weight for gestational age, as well as, increased relative risk for PTB and very PTB. 
Severity of maternal periodontal disease was also shown to be a predictor of more severe APOs. 
47,48 A meta-analysis by Vergnes, concluded that periodontal disease may be an independent risk 
factor for preterm low birth weight, with odds ratio of 2.83.66  
Boggess and colleagues evaluated the relationship between increased risk of PTB and 
fetal immune and inflammatory responses to oral microorganisms. Authors found fetal IgM 
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response to Campylobacter rectus, Peptostreptococcus micros, Prevotella nigrescens, Prevotella 
intermedia or Fusobacterium nucleatum in 35% of the cases and it was associated with an 
elevated risk of PTB (<35 weeks). Fetuses also show evidence of an immune response to 
infection with oral pathogens measured by the presence of TNF-α, PGE2, IL-1β, IL-6, and 8-
isoprostane. The risk for PTB was significantly increased when fetuses developed both an 
immune and an inflammatory response.13   
Reduced maternal IgG antibody response to periodontal pathogens has also been shown 
to be associated with increased risk of PTB.34 In a study by Offenbacher and colleagues, 2.9-fold 
higher prevalence of IgM seropositivity for one or more organisms of the Orange or Red 
complex was observed among preterm babies, as compared to term babies. The prevalence of 
positive fetal IgM to C. rectus was significantly higher for preterm as compared to full-term 
infants. Reduced maternal IgG antibody to periodontal pathogens of the Red complex was 
associated with an increased rate of PTB with odds ratio (OR) = 2.2. These findings support the 
theory that the lack of a protective maternal antibody response allows periodontal pathogens to 
travel in the blood and invade the intrauterine cavity, ultimately leading to APOs.36  
To date, interventions studies examining the effect of periodontal therapy during 
pregnancy on APOs present conflicting results. Michalowicz and colleagues found that 
periodontal treatment in pregnant women while safe for the pregnancy, does not significantly 
alter rates of preterm birth, low birth weight, or fetal growth restriction.38 A pilot study by 
Offenbacher and colleagues found periodontal intervention significantly reduced the odds ratio 
for PTB (OR 0.26; 95% CI 0.08-0.85).48 However, a later study by the same group found that 
periodontal therapy during pregnancy had no statistically significant effect in reducing the 
incidence of PTB.42 
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A meta-analysis by Polyzos and colleagues found that periodontal therapy during 
pregnancy is associated with significantly lower risk of PTB (OR 0.55, 95% CI 0.35-0.86), lower 
LBW (OR 0.48; 95% CI 0.23-1.00),although no difference was observed for spontaneous 
abortion or stillbirth (OR 0.73; 95% CI 0.41-1.31).53 In contrast, a systematic review and meta-
analysis by Rosa and colleagues found that periodontal treatment during pregnancy had no 
significant effect on rate of PTB (RR 0.90; 95% CI 0.68-1.19) and low birth weight  (RR 0.92; 
95% CI 0.71-1.20)57. Similar results were found in a meta- and trial sequential analysis by 
Schwendicke and colleagues, were periodontal intervention was shown to reduce the risk of 
APOs only in populations with high occurrence (>20%) of PTB and LBW.59  
Madianos and colleagues proposed a possible biological model for the association 
between PD and APOs. In these model, the authors emphasizes that hormonal changes during 
pregnancy lead to increased vascular permeability in oral tissues which facilitates periodontal 
pathogens to gain access to the systemic circulation, where they can travel to distant sites and 
reach the placenta and fetus. The presence of oral bacteria and their products in the intrauterine 
cavity elicits a fetal immune and inflammatory response characterized by production of IgM 
against periodontal pathogens and stimulates the release of inflammatory cytokines. If the 
immune response is able to contain the infection, no APOs should occur. 35 
However, if the infection is not controlled the increase in inflammatory mediators can 
induce premature rupture of membranes and uterine contraction, resulting in spontaneous 
abortion or PTB. This model also considers the possibility that inflammatory cytokines in 
gingival tissues can disseminate hematogenously and reach the uterine circulation, enhancing the 
inflammatory response in the intrauterine cavity. Furthermore, intrauterine infection can lead to 
downregulation of key genes for placental and fetal growth and development. This could cause 
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placental architectural changes that can impair the movement of nutrients into the placenta, 
ultimately leading to APOs such as low weight for gestational age and fetal mortality.35  
However, a gap in knowledge remains regarding whether oral pathogens can consistently 
reach and affect fetal tissues, such as the placenta and the umbilicus and whether this exposure is 
determined by the level of periodontitis. 
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CHAPTER 2: THE UMBILICAL AND PLACENTAL MICROBIOMES AND THEIR 
RELATIONSHIP WITH PRE-TERM BIRTH 
 
INTRODUCTION 
WHO defines preterm birth as babies born alive before 37 weeks of pregnancy are 
completed, with subcategories moderate-late preterm (32 to < 37 weeks), very preterm (28 to 
<32 weeks), and extremely preterm (<28 weeks). Worldwide an estimated 11.1% of all live 
births in 2010 were born preterm (14.9 million babies born before 37 weeks of gestation), with 
preterm birth rates increasing in most countries with reliable trend data. Direct complications of 
preterm birth account for one million deaths each year, and preterm birth is a risk factor in over 
50% of all neonatal deaths.4 The effect of preterm birth among some survivors may continue 
throughout life, impairing neuro-developmental functioning through increasing the risk of 
cerebral palsy, learning impairment and visual disorders and affecting long-term physical health 
with a higher risk of non-communicable disease.32 
Preterm births can be classified into two main categories: spontaneous births or provider-
initiated preterm birth.14 Spontaneous preterm labor can be initiated by different mechanisms, 
which include immunologically mediated processes, infection and inflammation, uterine 
overdistension, uteroplacental ischaemia or hemorrhage, stress, among others. 14, 33 Multiple 
maternal and fetal features have been linked to preterm birth, among these are pregnancy history, 
current pregnancy characteristics, maternal demographic characteristics,  infection, uterine 
contractions and cervical length, nutritional status, psychological characteristics, adverse 
behaviors, and biological and genetic markers.14 
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The pathogenesis of preterm birth while complex, it appears to be driven by microbial 
colonization and invasion.15 Studies have suggested that intrauterine infection could be the cause 
of 25-40% of preterm births. Vaginal microorganisms have been shown to reach the cervix, 
chorioamnion, placenta, or amniotic fluid. and trigger early labor via pro-inflammatory 
pathways. 34,37   Four major routes have been proposed to described microbial invasion of the 
uterine cavity: ascending from the vagina and cervix, hematogenous dissemination through the 
placenta, retrograde through the fallopian tubes, and introduction during invasive procedures; 
with the ascending pathway being the most common route.14 Previously, it was believed the 
placenta was a sterile environment in the absence of intrauterine infection.39 However, recent 
studies have demonstrated that the placenta has a microbiome, even in uneventful healthy 
pregnancies. Aagaard and colleagues, demonstrated that the placenta has its own microbiome 
with a composition most similar to the human oral microbiome. Further, the authors reported an 
association between the placental microbiome composition and APOs.1  
Oral microorganisms have been postulated to contribute to preterm birth.24,25,27,38 In fact, 
periodontitis, a common oral disease of bacterial etiology and potent inflammatory component is 
strongly associated with pre-term birth. Further, levels of periodontal pathogens, such as 
Porphyromonas gingivalis and Tannerella forsythia have been detected in significantly higher 
levels in subgingival biofilm samples of mothers who delivered preterm babies.22 In addition, 
those pathogens have also been detected more commonly in the amniotic fluid and subgingival 
plaque samples of patients who gave birth to preterm neonates.11 However, a gap in knowledge 
remains regarding whether oral pathogens can consistently reach and affect fetal tissues, such as 
the placenta and the umbilicus and whether this exposure is determined by the level of 
periodontitis. Therefore, the aim of this study was to compare the microbiomes of placenta and 
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umbilicus samples from women presenting periodontal diseases who experienced full term (FTB, 
n=22) and preterm births (PTB; <35 weeks) using 16S rRNA MiSeq Illumina sequencing.  
MATERIALS AND METHODS 
Study Population 
 Samples used in this study were collected from pregnant women previously enrolled in 
the Maternal Oral Therapy to Reduce Obstetric Risk (MOTOR U01DE014577) Study26 as part of 
the study demographic, medical and dental (periodontal) data were collected as well as maternal 
subgingival biofilm samples and fetal tissues (umbilicus and placenta). All participants of the 
MOTOR Study signed a consent that allowed the use of all the available biological samples 
collected and stored, for the purposes of the present investigation.  Inclusion criteria: pregnant 
and able to complete periodontal treatment prior to 23 weeks gestation, at least 16 years old at 
enrollment, minimum of 20 teeth present, three (3) or more periodontal sites with > 3mm clinical 
attachment loss. Exclusion criteria: multiple gestation, systemic medical conditions, rampant 
decay, symptomatic teeth or any other dental finding such as periodontal abscess or endodontic 
fistula that would preclude enrollment, chronic use of medications that cause gingival 
enlargement such as phenytoin, cyclosporin-A, or calcium channel antagonists, chronic use of 
steroids, or concomitant use of orthodontic appliances (braces). 
 For the present study, a case-control design with a ratio of 1:1 was employed. Case group 
consisted of 22 mothers who had preterm delivery (< 35 weeks gestational age), while the 
control group consisted of 22 mothers who had normal, term deliveries and uneventful 
pregnancies. Control cases were selected using a random sampling method. In the case group, a 
non-random sampling method was used due to the limited numbers of subjects in the MOTOR 
database. In this report we present the following data from each subject: maternal pre-partum and 
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post-partum plaque samples, as well as, placental and umbilical tissue samples collected at 
delivery. 
Sample Collection and Processing 
 Placental and umbilical cord tissue samples were obtained within the first hour of 
delivery. Samples were collected using sterile tissue tweezers or hemostat and scissors. Each 
sample was stored into a cryovial numbered for that tissue specimen. The cryovials were snap 
frozen in liquid nitrogen. Samples were stored temporarily on dry ice, transported to the 
laboratory at the University of North Carolina at Chapel Hill and subsequently stored at -80°C. 
The first step in preparation for the microbial analysis of the umbilical and placental tissues was 
tissue homogenization, using a sterile mortar and pestle and liquid nitrogen until a powder 
consistency was achieved. Immediately proceeded with DNA extraction using the MasterPure 
DNA Purification kit (Epicentre, Illumina, Madison, WI) according to the manufacturer’s 
recommendations. DNA quantification was performed using Quant-iTTM PicoGreen ® dsDNA 
Assay Kit (Thermo Fisher Scientific, Waltham, MA). Sample fluorescence was measured using a 
fluorescence microplate reader (excitation ~480 nm, emission ~520 nm).  
Library preparation and 16S rRNA sequencing   
 The protocol used has been described elsewhere (Furquim et al 2016).13 In brief, samples 
prepared for sequencing had a minimum DNA concentration of 10 ng/uL in at least 10 uL 
volume. A modified protocol was used for 16S rRNA amplicon sequencing library preparation.7 
The variable region V3-V4 of the 16S rRNA gene were PCR amplified using barcoded 341F and 
806R 16S primers.6 The amplicon size was approximately 460 bp. PCR products were purified 
(AMPure beads Beckman Coulter, Brea, CA) and quantified (Quant-iT™ PicoGreen ® dsDNA 
Reagent, Molecular Probes, Waltham, MA). Equimolar amounts of each library were pooled, 
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gel-purified, analyzed and quantified (2100 Bioanalyzer, DNA High Sensitivity chip;Agilent 
Technologies, Santa Clara, CA). The library mixture (6 picomolars spiked with 30% PhiX) were 
run on a MiSeq instrument (Illumina, San Diego, CA). Automated cluster generation and paired–
end sequencing using 500 cycle reagent kit were performed according to the manufacturer’s 
instructions.  
Clinical Measurements 
 During the MOTOR Study subjects received a comprehensive periodontal examination 
performed by calibrated dental examiners at baseline and delivery. The clinical examination 
protocol of the study has been described elsewhere (Offenbacher et al 2009).26. For all subjects, 
there are baseline and post-partum data for the following clinical parameters: plaque score 
gingival index, probing pocket depth (PD), bleeding on probing (BOP), and clinical attachment 
level (CAL).  
Data Analysis 
After removal of chimeric sequences and sequences that failed quality control, sequencing reads 
were evaluated using the QIIME analysis pipeline (Quantitative Insights Into Microbial Ecology, 
qiime.org, version 1.8)5 Reads were grouped into Operational Taxonomic Units (OTUs) using 
UCLUST 10 and the bacterial taxonomy was determined using HOMD and Greengenes. After 
taxonomic assignment, OTUs were combined with sample metadata.  Species-level taxonomy 
was determined using HOMINGS. The relative abundance of the taxa present in each sample 
was computed at the phylum and genus levels.  The demographic and clinical measurements of 
the study population were analyzed using Student’s t-test and Chi Square test. Microbial 
differences between samples from PTB and FTB were sought using Kruskall-Wallis  and 
Principal Component Analyses (PCA). Correlations between microbial taxa and periodontal 
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parameters were sought using the Spearman correlation coefficient. False discovery rate (FDR) 
was used to adjust for multiple comparisons. All statistical analysis was performed in SAS 
version 9.4. 
RESULTS 
Socio-Demographic and Clinical Characteristics of the Study Population 
A total of forty-four pregnant women were included in this study, with twenty-two 
mothers in the term group and twenty-two mothers in preterm group. Preterm and term groups at 
baseline did not differ in maternal age, marital status, maternal BMI, public assistance, previous 
pregnancy, or smoking history.  However, significant differences were observed regarding 
maternal race, with 62% of Caucasian mothers in the term group and 73% of African American 
mothers in the preterm group (Table 1). With regard to ante-partum clinical measures, both 
groups had similar mean gingival index (GI), plaque index (PI), bleeding on probing (BOP), 
extent of sites with probing depth (PD) at least 4mm, and attachment level (AL) at least 3mm. In 
terms of postpartum clinical measures, no differences were observed between groups (Table 1). 
Overall Sequencing Data and Microbial Profile 
All samples were sequenced in the same run, which generated a total of  reads,  and 
yielded, on average 2,911 reads (±3,376; median: 2,255) for placenta samples, ranging from 669 
to 22,630 reads and an average of 14, 741 reads (± 24,699; median: 3,378) for umbilicus 
samples, ranging from 653 to 121,896 reads (Table 2). Sequencing of placenta samples revealed 
8 different phyla, 84 genera, and 132 species. While, umbilicus samples revealed 8 different 
phyla, 100 genera, and 225 species. Comparison of sequencing results using HOMD and 
Greengenes Databases demonstrated similar results regarding percentage of unassigned genera 
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and most abundant genera detected (Table 3). However, certain differences regarding genera 
detection were also observed between databases (Table 4). 
Impact of Sample Type and Time of Delivery  
 Principal component analyses of placenta and umbilicus samples showed that the 
microbiome of the placenta is different from the umbilicus microbiome (Fig 1). When comparing 
the umbilicus PTB samples with FTB samples, principal component analysis showed a tendency 
for samples of the different groups to cluster together, suggesting that PTB and FTB samples 
exhibit distinct microbial profiles (Fig 2). 
Microbial Profiles in PTB/FTB  
Placenta Tissues  
 The most abundant phylum in placental tissues were: Firmicutes (mean relative 
abundance ± standard deviation) (FTB: 44.2% ± 14.2%, PTB: 40.9% ± 15.0%; p: 0.481), 
followed by Fusobacteria (FTB: 9.4% ± 9.0%, PTB: 15.0% ± 9.7%; p: 0.069) and 
Proteobacteria (FTB: 12.7% ± 10.4%, PTB: 9.3% ± 8.3%; p = 0.222) (Fig 3). The most 
abundant genera in placental samples were Veillonella (FTB: 16.1% ± 10.3%, PTB: 18.7% ± 
11.4%, p= 0.573), Fusobacterium (FTB: 9.4% ± 9.0%, PTB: 14.9% ± 9.8%, p= 0.076) and 
Streptococcus (FTB: 6.4% ± 6.5%, PTB: 6.4% ± 4.5%, p= 0.511). The following genera 
demonstrated significant differences between groups: Slackia (FTB: 0.0% ± 0.0%, PTB: 0.6% ± 
1.7%, p= 0.04) and Actinomyces (FTB: 0.1% ± 0.5%, PTB: 0.7% ± 1.4%, p= 0.03) (Fig 5).  
 The most abundant species were Neisseria elongata (FTB: 4.78% ± 4.95%, PTB: 3.84% 
± 4.51%, p= 0.53), Gemella morbillorum (FTB: 3.21% ± 4.80%, PTB: 3.98% ± 5.09%, p= 0.45), 
Streptococcus constellatus (FTB: 3.99% ± 4.44%, PTB: 3.16% ± 3.68%, p= 0.52) and 
Anaeroglobus geminatus (FTB: 2.39% ± 3.28, PTB: 3.19% ± 4.84%, p= 0.66) (Fig 7). Several 
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periodontal microorganisms were detected in placental samples, including Fretibacterium 
fastidiosum, Campylobacter gracilis, Parvimonas micra, Capnocytophaga gingivalis, Prevotella 
nigrescens, Eikenella corrodens and Treponema denticola.  Key periodontal pathogens such as 
Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis and Tanerella forsythia, 
were not detected. 
Umbilicus Tissues 
 Most abundant phylum in umbilical tissues were: Firmicutes (mean relative abundance + 
standard deviation) (FTB: 32.0% ± 17.0%, PTB: 36.6% ± 20.3%; p= 0.851), followed by 
Proteobacteria (FTB: 15.1% ± 20.5%, PTB: 8.1% + 7.0%; p= 0.467) and Synergistetes (FTB: 
7.2% ± 12.7%, PTB: 7.7% ± 14.7%; p= 0.823) (Fig 4). The most abundant genera were 
Veillonella (FTB : 9.7% ± 8.5%, FTB: 18.9% ± 18.2%, p = 0.064), Pyramidobacter (FTB: 6.2% 
± 12.2%, PTB: 6.5% ± 14.7%, p = 0.807), and Fusobacterium (FTB: 6.4% ± 65.5%, PTG: 6.4% 
± 6.4%, p = 0.814). The following genera demonstrated significant differences between groups: 
Bifidobacterium (FTB: 2.2% ± 3.1, PTB: 0.6% ± 1.0%, p= 0.04), Megasphaera (FTB: 2.3% ± 
2.8%, PTB: 0.7% ± 1.0%, p= 0.02), and Lactobacillus (FTB: 3.7% ± 8.3%, PTB: 1.4% ± 4.5%, 
p= 0.01) (Fig 6).  
 The most abundant species were: P. piscolens (FTB: 6.1% ± 11.8%, PTB: 6.3% ± 14.5%, 
p= 0.64),  G. morbillorum (FTB: 1.5% ± 1.7%, PTB: 1.8% ± 2.5%, p= 0.98),  Streptococcus 
constellatus (FTB: 1.8% ± 2.0%, PTB: 1.7% ± 2.2%, p=0.79), and Neisseria elongata (FTB: 
1.5% ± 2.3%, PTB: 1.6 % ± 3.0%, p= 0.93). The following species were found to be 
significantly different between groups: Granulicatella adiacens (FTB: 0.2% ± 0.6%, PTB: 1.2% 
± 1.5%, p=0.01), Anaeroglobus geminatus (FTB: 2.1% ± 2.7%, PTB: 0.5% ± 0.9%, p=0.03), 
Lactobacillus iners (FTB: 2.3% ± 6.7%, PTB: 0.5% ± 2.2%, p=0.02), Peptostreptococcaceae 
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[XI][G-7] HOT 081 (FTB: 0.0 ± 0.1, PTB: 0.4 ± 1.1; p=0.02), and Eubacterium nodatum (FTB: 
0.0 ± 0.1, PTB: 0.4 ± 0.7; p= 0.04) (Fig 8). Several periodontal microorganisms were detected in 
umbilical samples, including Campylobacter gracilis, Fretibacterium fastidiosum, 
Fusobacterium HOT 204,  Parvimonas micra, P. gingivalis, Prevotella intermedia,  Prevotella 
nigrescens and Treponema denticola. Key periodontal pathogens such as Aggregatibacter 
actinomycetemcomitans and Tanerella forsythia, were not detected. 
Unique Taxa Detected 
 The only genus detected in both placental and  umbilical FTB samples was 
Ruminococcaceae. Mycoplasma, Peptoniphilaceae, and Shuttleworthia genera were detected in 
both placental and umbilical PTB samples (Table 5). Some species were unique to FTB samples 
such as Gardenella vaginalis, Peptosreptococcacea [XI][G7], and Mobiluncus mulieris (Table 
6). While, certain species were unique to PTB samples such as Bacteroides heparinolyticus, 
Enterococcus faecalis, and Pseudoramibacter alactolyticus (Table 7).  
Correlations between Placenta Samples Microbial Profile and Clinical Measurements 
 Positive correlations were observed between presence of C. tuscaniense in placenta 
samples and extent of AL >3mm (CC: 0.495, p = 0.001), extent of PD >4mm (CC: 0.302 , p= 
0.046), GI (CC: 0.405, p=0.006), and PI (CC: 0.422, p=0.0064. Leptotrichia HOT 223 showed 
positive correlations for extent of AL >3mm (CC: 0.495, p = 0.001), extent of PD >4mm (CC: 
0.302 , p= 0.046), GI (CC: 0.405, p=0.006), and PI (CC: 0.422, p=0.0064. While, Fusobacterium 
HOT 204 showed positive correlations for extent of AL >3mm (CC: 0.389, p = 0.009), GI (CC: 
0.344, p=0.022), and PI (CC: 0.386, p=0.010). 
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Correlations between Umbilicus Samples Microbial Profile and Clinical Measurements 
 Positive correlations were found between presence of P. gingivalis in umbilical tissues 
and extent of AL >3mm (CC: 0.482, p = 0.001), GI (CC: 0.365, p=0.015), and PI (CC: 0.408, 
p=0.006). The presence of  TM7 HOT 347 in umbilical tissues showed positive correlations with 
extent of AL >3mm (CC: 0.439, p=0.003), extent of PD >4mm (CC: 0.388, p=0.009), GI (CC: 
0.398, p=0.008), and GI (CC:0.378, p= 0.011). Presence of  Prevotella loescheii in umbilical 
tissues showed a positive correlation with GI (CC: 0.383, p=0.01) and PI (CC: 0.42, p= 0.005) 
(Table 8). 
DISCUSSION 
The intrauterine cavity was previously thought to be a sterile environment in the absence 
of intrauterine infection.39 Recent studies, have demonstrated the presence of a placental 
microbiome even in uneventful, healthy pregnancies. Fetal membranes from PTB and TB have 
shown presence of bacteria, although, a more diverse microbial profile was found in PTB.19 
Gram-positive and negative intracellular bacteria have been identified in placental basal plates of 
both preterm and term pregnancies.37 Aagaard and colleagues, demonstrated the presence of a 
placental microbiome  in healthy pregnancies, with a microbial composition most similar to the 
human oral microbiome.1  
Our study demonstrated the presence of a low-abundance placental microbiome in both 
term and preterm births. Furthermore, we were able to describe the microbial profile of the 
umbilicus for the first time.  Some of the most common phylum detected in our samples 
Firmicutes, Fusobacteria, and Proteobacteria have been previously described in the literature as 
part of the placental microbiome.1 Among the genera detected in our study were Fusobacterium, 
Streptococcus, and Lactobacillus; these were described by Payne and colleagues as some of the 
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most commonly detected microorganisms in the placenta and amniotic fluid.30 Similar findings 
were demonstrated by Satokari and colleagues, who were able to detect Bifidobacterium and and 
Lactobacillus in placenta samples from both vaginal and cesarean deliveries.36 
Consistent with previous studies, a PCA analysis of our samples demonstrated 
differences in the microbial profile of the PTB and FTB samples. A study by Doyle and 
colleagues,  compared the microbiome of placental membranes  of very preterm and  term 
deliveries;  using 16S rDNA sequencing they were able to identified 1 family 
(Enterobacteriaceae) and 6 genera (Fusobacterium, Streptococcus, Mycoplasma, Aerococcus, 
Gardnerella, and Ureaplasma) that were present in greater relative abundances in PT samples or 
absent in term deliveries.9 Zheng and colleagues, investigated whether the placental microbiome 
varies with low birth weight in full-term infants and found significant variations in the 
composition of placenta microbiota between LBW and NBW infants at phylum and genus levels. 
Authors concluded that in fact the placental microbiome varies in association with low birth 
weight in full-term infants.41 Similarly, differences in placental microbiome have been associated 
with the development of Preeclampsia and excess maternal gestational weight gain.2,3,20  
The pathogenesis of PTB seems to be complex and multifactorial, however, infection of 
the intrauterine cavity seems to be one of the leading causes.15,23,30 In recent years, mounting 
evidence supporting  the establishment of the placental microbiome via hematogenous 
dissemination has been reported. The placental microbiome has been shown to be more similar 
to the oral microbiome than any other microbiome in the human body.1 These findings, suggest 
that oral microorganisms have the ability to invade tissues and disseminate in the blood to reach 
the intrauterine cavity.23 Hematogenous translocation of bacteria into the placenta was 
demonstrated in  pregnant murine model, in which intravenous injection of F. nucleatum resulted 
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in premature delivery, nonsustained live births, and stillbirths.17 F. nucleatum has been shown to 
have the ability to  adhere and invade epithelial and endothelial cells via novel FadA adhesion; in 
mixed infections, F. nucleatum could facilitate the hematogenous spread of other 
microorganisms.12 Bergeyella was detected in a case of PTB with intrauterine infection, the same 
strain of Bergeyella was detected in the subgingival plaque of the mother but in the vaginal 
tract.16 In our study, we were able to identify several genera common to the oral cavity such as 
Veillonella, Fusobaterium, Streptococcus, Pyramidobacter, and Prevotella. Interestingly, 
Pyramidobacter genus has only been described in the oral cavity.8 When comparing the results 
from HOMD and Greengenes databases, once again the majority of the genera detected were 
common to the oral cavity. Several studies have demonstrated a strong association between PTB 
and periodontal disease.24,25,27,38	  Our samples demonstrated presence of  multiple periodontal 
microorganisms that have been associated to APOs were detected in our samples: E. corrodens, 
P. intermedia, P. gingivalis, P. micra, P. nigrescens, and T. denticola.18,31  
There are limitations in the present study. The first one is its sample size. This was a pilot 
study, therefore, we were not able to performed power calculations.  Also, we were limited by 
the amount of available samples from subjects that met all the criteria for our study. A second 
limitation of the present study is its cross sectional design, which precludes any inference on a 
causal role of the microbiome in PTB. A third limitation is the low biomass of our samples. 
Previously, it has been suggested that the low biomass of placenta samples preclude from 
differentiating between placental DNA and contamination (i.e. dust and commercial reagents) 
introduced during DNA purification.21 The collection and processing of our samples were 
performed following a sterile protocol. To rule out contamination, we obtained swabs from our 
sterile mortar and pestles before use and performed DNA extraction of those control samples. 
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Negative numbers were obtained when performing DNA quantification using Quant-iTTM 
PicoGreen ® dsDNA Assay Kit (Thermo Fisher Scientific, Waltham, MA), therefore, samples 
did not contain enough DNA to allow 16S rRNA sequencing to be performed. Furthermore, we 
were not able to detect common environmental contaminants such as Propionibacterium species 
in our samples.35,40 
CONCLUSIONS 
 We demonstrated that the umbilicus has a microbiome, that it is the case even in 
uneventful deliveries and it is different from that of the placenta. It may contribute to PTB via 
the presence of high levels of Veillonella, Fusobacterium and Peptostreptococcacea species. The 
presence of P. gingivalis in the umbilical microbiome was positively correlated with periodontal 
parameters.  
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Table 1:  Demographics and Periodontal Parameters of Study Population  
 
Term Preterm p(value
Maternal/Race
!!African!American 4!(27%) 11!(73%)
!!Caucasian 18!(62%) 11!(38%) 0.03
Mean/(SD)
Maternal/Age 25.2!(3.6) 25.7!(6.7) 0.74
Mean/(SD)/Pre/Pregnancy
BMI 26.5!(4.5) 27.9!(5.3) 0.36
Married 11!(55%) 9!(45%)
!!Not!Married 11!(46%) 13!(54%) 0.54
WIC 18!(51%) 17!(49%)
!!No 4!(44%) 5!(56%) 0.71
Nulliparous 4!(36%) 7!(64%)
!!No 18!(55%) 15!(46%) 0.3
Smoking/During/Pregnancy 3!(60%) 2!(40%)
!!No 19!(49%) 20!(51%) 0.63
Mean/(SD)
Extent/AL/>=3mm 18.5!(9.6) 19.0!(12.3) 0.9
Mean/(SD)
Extent/PD/>=4mm 26.3!(14.7) 24.3!(19.1) 0.69
Mean(SD)//BOP 47.7!(29.4) 44.0!(31.7) 0.66
Mean/(SD)/GI 1.3!(0.4) 1.2!(0.5) 0.26
Mean/(SD)/PI 2.9!(0.5) 2.8!(0.6) 0.56
Mean/(SD)
Extent/AL/>=3mm 12.9!(14.4) 10.7!(13.0) 0.61
Mean/(SD)
Extent/PD/>=4mm 27.6!(19.1) 22.1!(19.8) 0.37
Mean/(SD)/BOP 42.7!(28.1) 26.1!(25.4) 0.06
Mean/(SD)/GI 1.1!(0.4) 0.9!(0.4) 0.13
Mean/(SD)/PI 3.0!(0.5) 2.8!(0.6) 0.36
Ante/Partum/Clinical/Measures
Post/Partum/Clinical/Measures
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Table 2: Descriptive Statistics of Sequencing Results 
 
Sample Available+Samples Mean+reads+±+SD Median Range Samples+<1000+reads
Samples+<5000+
reads
Placenta 44 2,911&±&3,&376 2,255 669,22,630 5 36
Umbilicus 44 14,&741&±&24,&699 3,378 653,121,896 3 23
 
 
 
 
 
Table 3: Comparison of Databases: HOMD versus Greengenes 
 
#OTU%ID%GREENGENES Mean SD #OTU%ID%HOMD Average SD
Unassigned 22.80% 20.90% Unassigned 25.30% 21.90%
Veillonella 15.90% 13.00% Veillonella 15.80% 13.00%
Fusobacterium 9.30% 8.50% Fusobacterium 9.30% 8.50%
Streptococcus 5.60% 4.80% Streptococcus 5.70% 5.00%
Pyramidobacter 4.20% 10.00% Pyramidobacter 4.20% 10.00%
Prevotella 3.00% 4.00% Prevotella 3.00% 4.00%
f__Neisseriaceae 3.00% 4.30% Kingella 3.00% 4.10%
f__Enterobacteriaceae 2.80% 9.90% f__Enterobacteriaceae 1.60% 6.60%
f__Gemellaceae 2.70% 3.70% Gemella 2.70% 3.70%
Megasphaera 2.40% 3.60% Megasphaera 2.40% 3.60%
Campylobacter 2.30% 3.50% Campylobacter 2.30% 3.50%
Lactobacillus 2.10% 5.10% Lactobacillus 2.10% 5.10%
Parvimonas 1.90% 3.20% Parvimonas 1.90% 3.20%
Dethiosulfovibrionaceae;g__TG5 1.60% 3.70% Fretibacterium 1.60% 3.70%
Corynebacterium 1.40% 2.00% Corynebacterium 1.40% 2.00%  
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Table 4: Distinct Taxonomy Between Databases 
 
#OTU%ID%GREENGENES Mean SD #OTU%ID%HOMD Average SD
Ureaplasma 1.10% 9.00% Kluyvera 1.20% 7.60%
f_[Mogibacteriaceae] 0.40% 1.10% Afipia 0.10% 0.20%
[Ruminococcus] 0.10% 0.40% Arsenicicoccus 0.10% 0.70%
f_Bifidobacteriaceae 0.20% 1.30% Atopobium 0.10% 0.30%
Brachybacterium 0.10% 0.70% Bacteroidetes_[GI6] 1.00% 1.90%
Bradyrhizobium 0.10% 0.20% Bergeyella 0.20% 1.40%
Brevibacterium 0.30% 1.30% Clostridiales_[FI3][GI1] 1.00% 4.70%
Cloacibacterium 0.10% 1.40% Lachnoanaerobaculum 0.20% 1.00%
Clostridium 0.90% 4.60% Lachnospiraceae_[GI2] 0.10% 0.40%
Collinsella 0.10% 0.50% Lachnospiraceae_[GI8] 0.20% 0.60%
Coprococcus 0.10% 0.30% Leptotrichia 0.10% 0.30%
f_Coriobacteriaceae 0.10% 0.40% Peptostreptococcaceae_[XI][GI1] 0.20% 0.60%
Faecalibacterium 0.10% 0.80% Peptostreptococcaceae_[XI][GI6] 0.10% 0.40%
Gemella 0.10% 0.50% Peptostreptococcaceae_[XI][GI7] 0.70% 1.80%
Lactococcus 0.10% 0.80% Ralstonia 0.10% 0.20%
Methylobacterium 0.20% 0.90%
Odoribacter 1.00% 1.90%
Thermus 0.10% 0.30%
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Table 5: Unique Genera to FTB or PTB 
 
PTB FTB 
Placenta Umbilicus Placenta Umbilicus 
Shuttleworthia 
Eggerthella 
Anaeroglobus 
Propionibacterium 
Capnocytophaga 
Leptotrichia 
Mycobacterium 
Mycoplasma 
Sneathia 
Peptoniphilaceae 
Peptostreptococcaceae 
[G9] 
Slackia 
Haemophilus 
 
Peptoniphilaceae 
Bacteroides [G2] 
Shuttleworthia 
Microbacterium 
Tannerella 
Stomatobaculum 
Mycoplasma 
 
Lachnospiraceae [G2] 
Ruminococcaceae 
Pseudomonas 
Finegoldia 
Peptoniphilus 
Enterococcus 
Arsenicicoccus 
Bergeyella 
Clostridiales [F3][G1] 
 
Ruminococcaceae 
Scardovia 
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Table 6: Species Unique to Full-Term Birth 
 
PLACENTA UMBILICUS 
Agrobacterium tumefaciens 
Alloprevotella HOT 308 
Alloprevotella rava 
Bacteroides zoogleoformans 
Campylobacter gracilis 
Catonella morbi 
Delfia acidovorans 
Enterococcus faecalis 
Finegoldia magna 
Gardnerella vaginalis 
Gemella morbillorum 
Lactococcus lactis 
Megasphaera HOT 841 
Neisseria oralis 
Oribacterium asaccharolyticum 
Oribacterium sinus 
Peptoniphilus lacrimalis 
Peptostreptococcaceae [XI][G7] 
Prevotella denticola 
Prevotella HOT 376, HOT 300 
Prevotella loescheii 
Prevotella saccharolytica 
Rothia aeria 
 
Actinomyces HOT 175 
Actinomyces timonensis 
Bacteroides pyogenes 
Bacteroidetes [G-3] HOT365 
Bulleidia_extructa 
Butyrivibrio HOT 455 
Capnocytophaga HOT 335 
Capnocytophaga HOT 412 
Capnocytophaga HOT 901 
Capnocytophaga sputigena 
Chlamydophila pneumoniae 
Corynebacterium mucifaciens 
Haemophilus parainfluenzae 
Lachnospiraceae[G-9] HOT 924 
Leptotrichia HOT 217 
Mitsuokella HOT 131 
Mobiluncus mulieris 
Neisseria HOT 523 
Olsenella profusa 
Parvimonas micra 
Pedobacter HOT 933 
Peptinophilaceae[G-2] HOT 790 
Peptostreptococcaceae[XI][G-1] sulci 
Peptostreptococcaceae[XI][G-7] 
Porphyromonas pasteri 
Porphyromonas HOT 930 
Prevotella fusca 
Prevotella intermedia 
Prevotella multisaccharivorax 
Prevotella oulorum 
Prevotella HOT 376 
Propionibacterium avidum 
Proteus mirabilis 
Selenomonas HOT 501 
Streptococcus agalactiae 
Treponema HOT 260 
Turicella otitidis 
Veillonella atypica 
Veillonella rogosae 
Veillonellaceae[G-1] HOT 155 
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Table 7: Species Unique to Preterm Birth 
 
PLACENTA UMBILICUS 
Bacteroides heparinolyticus 
 Capnocytophag gingivalis 
 Corynebacterium tuscaniense 
 Fusobacterium HOT 205 
 Leptotrichia HOT 223 
 Mycoplasma hominis 
 Peptoniphilaceae [G1] HOT 113 
 Peptostreptococcus anaerobius 
 Prevotella baroniae 
 Prevotella bivia 
 Prevotella maculosa 
 Prevotella melaninogenica 
 Prevotella nigrescens 
 Propionibacterium acnes 
 Pseudoramibacter alactolyticus 
 Sneathia sanguinegens 
 Stenotrophomonas maltophilia 
 Streptococcus agalactiae 
 Streptococcus sobrinus 
 Veillonella HOT 780 
  
Actinomyces gerencseriae 
Actinomyces oris 
Atopobium parvulum 
Bacteroides heparinolyticus 
Bergeyella HOT 907 
Cardiobacterium hominis 
Corynebacterium durum 
Eggerthella lenta 
Enterococcus faecalis 
Haemophilus parainfluenzae 
Haemophilus pittmaniae 
Lachnospiraceae [G2] HOT 096 
Lachnospiraceae [G7] HOT 163 
Lactobacillus jensenii 
Leptotrichia HOT 417 
Leptotrichia HOT 463 
Neisseria flava 
Neisseria flavescens 
Neisseria weaveri 
Pedobacter HOT 321 
Peptoniphilaceae [G3] HOT 929 
Peptostreptococcaceae [XI][G5], [XI][G4], 
[XI][G7] 
Porphyromonas HOT 275 
Prevotella loescheii 
Prevotella scopos 
Pseudomonas HOT 032 
Pseudomonas otitidis 
Pseudoramibacter alactolyticus 
Rothia aeria 
Selenomonas HOT 478 
Stomatobaculum HOT 373 
Treponema HOT 373 
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Table 8: Correlations between Baseline Clinical Parameters and Umbilicus Microbiome 
 
Oral%Species
Coefficient p"value Coefficient p"value Coefficient p"value Coefficient p"value Coefficient p"value
Actinomyces_sp_HOT_175 0.362 0.016
Atopobium_parvulum 0.307 0.042
Bacteroidales[GA2]_sp_HOT_274 00.313 0.038
Bifidobacterium_longum 0.314 0.038
Gemella_morbillorum 0.310 0.041
Gemella_morbillorum
Gemella_morbillorum 0.306 0.043
Lactococcus_lactis 0.456 0.002
Mitsuokella_multacida 0.431 0.004
Peptoniphilus_lacrimalis 0.484 0.001 0.331 0.028 0.419 0.005 0.410 0.006
Porphyromonas_gingivalis 0.482 0.001 0.365 0.015 0.408 0.006
Prevotella_loescheii 0.519 0.000 0.320 0.034 0.383 0.010 0.420 0.005
Prevotella_nigrescens 00.377 0.012
Prevotella_oralis 00.370 0.014
Ruminococcaceae[GA3]_sp_HOT_381 0.431 0.004
Selenomonas_noxia 0.459 0.002
Stenotrophomonas_maltophilia 0.408 0.006
Streptococcus_sobrinus 00.327 0.030
TM7[GA1]_sp_HOT_347 0.439 0.003 0.388 0.009 0.398 0.008 0.378 0.011
Extent%AL%>=%3mm%
(nal_3/npdsites)
Extent%PD%>=%4mm%
(npd_4/npdsites)
Extent%BOP%(nbl/nblsites) Average%Gingival%Index Average%Plaque%Score
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Figure 1:  Principal Component Analyses of placenta and umbilicus samples. (Placenta: 
red, Umbilicus: green). 
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Figure 2:  Principal Component Analyses of Umbilicus PTB and FTB samples. (FTB: blue, 
PTB: red). 
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Figure 3:  Mean relative abundance ( % ±	  SD) of the most prevalent phyla detected in 
placenta samples  (FTB: blue, PTB: red). 
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Figure 4:  Mean relative abundance ( % ± SD)  of the most prevalent phyla detected in 
umbilicus samples  (FTB: blue, PTB: red). 
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Figure 5:  Mean relative abundance ( % ±	  SD)   of the most prevalent genera detected in 
placenta samples  (FTB: blue, PTB: red). ^p=0.01, ^^p=0.02, *p=0.03, **p=0.04 (Differences 
did not reach FDR-adjusted statistical significance).  
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Figure 6:  Mean relative abundance ( % ±	  SD) of the most prevalent genera detected in 
umbilicus samples  (FTB: blue, PTB: red). ^p=0.01, ^^p=0.02, *p=0.03, **p=0.04 (Differences 
did not reach FDR-adjusted statistical significance). 
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Figure 7:  Mean relative abundance ( % ±	  SD) of the most prevalent species detected in 
placenta samples  (FTB: blue, PTB: red). ^p=0.01, ^^p=0.02, *p=0.03, **p=0.04 (Differences 
did not reach FDR-adjusted statistical significance).  
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Figure 8:  Mean relative abundance ( % ±	  SD) of the most prevalent species detected in 
umbilicus samples  (FTB: blue, PTB: red). ^p=0.01, ^^p=0.02, *p=0.03, **p=0.04 (Differences 
did not reach FDR-adjusted statistical significance).
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CHAPTER 3: PERIODONTAL DISEASES & PRE-TERM BIRTH: INSIGHTS FROM 
THE PLACENTAL, UMBILICAL AND ORAL MICROBIOMES 
 
INTRODUCTION 
Since the early 1990’s periodontal disease has been suggested to have a role in the 
pathogenesis of preterm births (< 37 weeks gestational age). Each year, preterm birth affects 
almost 500,000 infants born in the U.S. In an average week, over 8000 infants are born 
prematurely at less than 37 weeks’ gestation. Blencowe and colleagues ranked the U.S. as the 
sixth country with the greatest number of preterm births in the year 2010.1. The effect of preterm 
birth among some survivors may continue throughout life, impairing neuro-developmental 
functioning through increasing the risk of cerebral palsy, learning impairment and visual 
disorders and affecting long-term physical health with a higher risk of non-communicable 
disease. 33 
The pathogenesis of preterm birth while complex, it appears to be driven by microbial 
colonization and invasion.12 Oral microorganisms have been postulated to contribute to preterm 
birth. 21,23,25, 27,28,40 In fact, periodontitis, a common oral disease of bacterial etiology and potent 
inflammatory component is strongly associated with pre-term birth. Furthermore, levels of 
periodontal pathogens, such as Porphyromonas gingivalis and Tannerella forsythia have been 
detected in significantly higher levels in subgingival biofilm samples of mothers who delivered 
preterm babies.19 In addition, those pathogens have also been detected more commonly in the 
amniotic fluid and subgingival plaque samples of patients who gave birth to preterm neonates.8  
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Human studies have shown evidence of oral microorganisms translocation to the 
intrauterine cavity. Periodontal pathogens such as P. gingivalis, Campylobacter rectus, T. 
forsythia, and Fusobacterium nucleatum have been detected in the amniotic fluid of mother’s 
with subgingival plaque samples positive for such pathogens.8,18 F. nucleatum has been detected 
in chorionic tissues of high-risk pregnant women, but not in tissues of normal pregnant women. 
Authors found that F. nucleatum is capable of inducing elevated production of IL-6 and CRH 
production in chorion-derived cells. 39 In a case report of a term stillbirth, F. nucleatum was 
shown to translocate hematogenously to the placenta and fetus, in  a mother whom subgingival 
plaque was positive for this microorganism.13 Early association studies demonstrated that 
periodontal disease is a statistically significant risk factor for  preterm low birth weight (PLBW) 
with odd ratios of 7.9  for all PLBW cases.28 A meta-analysis by Vergnes, concluded that 
periodontal disease may be an independent risk factor for preterm low birth weight, with odds 
ratio of 2.83.40  
Fetal IgM response to Campylobacter rectus, Peptostreptococcus micros, Prevotella 
nigrescens, Prevotella intermedia, or Fusobacterium nucleatum has been associated with an 
elevated risk of PTB (<35 weeks).2 Reduced maternal IgG antibody response to periodontal 
pathogens has also been shown to be associated with increased risk of PTB.19 In a study by 
Madianos and colleagues 21, found a  2.9-fold higher prevalence of IgM seropositivity for one or 
more organisms of the Orange or Red complex among preterm babies, as compared to term 
babies. The prevalence of positive fetal IgM to C. rectus was significantly higher for preterm as 
compared to full-term infants. A reduced maternal IgG antibody to periodontal pathogens of the 
Red complex was associated with an increased rate of PTB with odds ratio (OR) = 2.2. The 
findings of this study provide support to the theory that the lack of a protective maternal antibody 
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response allows periodontal pathogens to travel in the blood and invade the intrauterine cavity, 
ultimately leading to APOs.21 
Interventions studies to date, examining the effect of periodontal therapy during 
pregnancy on APOs present conflicting results, while some studies show a positive effect of 
periodontal treatment on prevention of APOs, others show no benefit.22,24,30,32,36 However, a gap 
in knowledge remains regarding whether oral pathogens can consistently reach and affect fetal 
tissues, such as the placenta and the umbilicus and whether this exposure is determined by the 
level of periodontitis. The aim of the present study was to compare the microbiomes of placenta 
and umbilicus samples from 44 women presenting periodontal diseases who experienced full 
term (FTB, n=22) and preterm births (PTB; <35 weeks, n=22) in relation to the levels of 
maternal subgingival periodontal species in each group pre and post-partum 
MATERIALS AND METHODS 
Study Population 
 Samples used in this study were collected from pregnant women previously enrolled in 
the Maternal Oral Therapy to Reduce Obstetric Risk (MOTOR U01DE014577) Study24; as part 
of the study demographic, medical and dental (periodontal) data were collected as well as 
maternal subgingival biofilm samples and fetal tissues (umbilicus and placenta). All participants 
of the MOTOR Study signed a consent that allowed the use of all the available biological 
samples collected and stored, for the purposes of the present investigation.  Inclusion criteria: 
pregnant and able to complete periodontal treatment prior to 23 weeks gestation, at least 16 years 
old at enrollment, minimum of 20 teeth present, three (3) or more periodontal sites with ≥ 3mm 
clinical attachment loss. Exclusion criteria: multiple gestation, systemic medical conditions, 
rampant decay, symptomatic teeth or any other dental finding such as periodontal abscess or 
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endodontic fistula that would preclude enrollment, chronic use of medications that cause gingival 
enlargement such as phenytoin, cyclosporin-A, or calcium channel antagonists, chronic use of 
steroids, or concomitant use of orthodontic appliances (braces). 
 For the present study, a case-control design with a ratio of 1:1 was employed. Case group 
consisted of 22 mothers who had preterm delivery (< 35 weeks gestational age), while the 
control group consisted of 22 mothers who had normal, term deliveries and uneventful 
pregnancies. Control cases were selected using a random sampling method. In the case group, a 
non-random sampling method was used due to the limited numbers of subjects in the MOTOR 
database. In this report we present the following data from each subject: maternal pre-partum and 
post-partum plaque samples, as well as, placental and umbilical tissue samples collected at 
delivery 
Sample Collection and Processing 
 Plaque samples were collected during the periodontal exam visit. Plaque were sampled 
from the deepest probed site in each quadrant. The site was isolated with a cotton roll and gross 
supragingival plaque or debris was removed. Samples were taken by placing a sterile curette at 
the base of each sulcus. Samples were stored separately at -20°C in a labeled vial containing TE 
and sodium hydroxide, added after collection. Since samples were stored in sodium hydroxide 
DNA extraction could not be performed, therefore, all plaques samples were processed using the 
checkerboard DNA-DNA hybridization method described by Socransky and colleagues. 37,38 
DNA probes from 41 bacterial species were used.  
 Placental and umbilical cord tissue samples were obtained within the first hour of 
delivery. Samples were collected using sterile tissue tweezers or hemostat and scissors. Each 
sample was stored into a cryovial numbered for that tissue specimen. The cryovials were snap 
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frozen in liquid nitrogen. Samples were stored temporarily on dry ice, transported to the 
laboratory at the University of North Carolina at Chapel Hill and subsequently stored at -80°C. 
The first step in preparation for the microbial analysis of the umbilical and placental tissues was 
tissue homogenization, using a sterile mortar and pestle and liquid nitrogen until a powder 
consistency was achieved. Immediately proceeded with DNA extraction using the MasterPure 
DNA Purification kit (Epicentre, Illumina, Madison, WI) according to the manufacturer’s 
recommendations. DNA quantification was performed using Quant-iTTM PicoGreen ® dsDNA 
Assay Kit (Thermo Fisher Scientific, Waltham, MA). Sample fluorescence was measured using a 
fluorescence microplate reader (excitation ~480 nm, emission ~520 nm).  
Library preparation and 16S rRNA sequencing   
 The protocol used has been described elsewhere (Furquim et al 2016)11. In brief, samples 
prepared for sequencing had a minimum DNA concentration of 10 ng/uL in at least 10 uL 
volume. A modified protocol was used for 16S rRNA amplicon sequencing library preparation.5 
The variable region V3-V4 of the 16S rRNA gene were PCR amplified using barcoded 341F and 
806R 16S primers.4 The amplicon size was approximately 460 bp. PCR products were purified 
(AMPure beads Beckman Coulter, Brea, CA) and quantified (Quant-iT™ PicoGreen ® dsDNA 
Reagent, Molecular Probes, Waltham, MA). Equimolar amounts of each library were pooled, 
gel-purified, analyzed and quantified (2100 Bioanalyzer, DNA High Sensitivity chip;Agilent 
Technologies, Santa Clara, CA). The library mixture (6 picomolars spiked with 30% PhiX) were 
run on a MiSeq instrument (Illumina, San Diego, CA). Automated cluster generation and paired–
end sequencing using 500 cycle reagent kit were performed according to the manufacturer’s 
instructions. The entire protocol is described in supplemental material. 
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Clinical Measurements 
 During the MOTOR Study subjects received a comprehensive periodontal examination 
performed by calibrated dental examiners at baseline and delivery. The clinical examination 
protocol of the study has been described elsewhere (Offenbacher et al 2009).24 For all subjects, 
there are baseline and post-partum data for the following clinical parameters: plaque score 
gingival index, probing pocket depth (PD), bleeding on probing (BOP), and clinical attachment 
level (CAL).  
Data Analysis 
After removal of chimeric sequences and sequences that failed quality control, 
sequencing reads were evaluated using the QIIME analysis pipeline (Quantitative Insights Into 
Microbial Ecology, qiime.org, version 1.8) 3(Caporaso et al. 2010). Reads were grouped into 
Operational Taxonomic Units (OTUs) using UCLUST 7(Edgar 2010) and the bacterial taxonomy 
was determined using HOMD and Greengenes. After taxonomic assignment, OTUs were 
combined with sample metadata.  Species-level taxonomy was determined using HOMINGS. 
The relative abundance of the taxa present in each sample was computed at the phylum and 
genus levels.  The demographic and clinical measurements of the study population were 
analyzed using Student’s t-test and Chi Square test. Microbial differences between samples from 
PTB and FTB were sought using Kruskall-Wallis  and Principal Component Analyses (PCA). 
Correlations between microbial taxa and periodontal parameters were sought using the Spearman 
correlation coefficient. False discovery rate (FDR) was used to adjust for multiple comparisons. 
All statistical analysis was performed in SAS version 9.4. 
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RESULTS 
Socio-Demographic and Clinical Characteristics of the Study Population  
A total of forty-four pregnant women were included in this study, with twenty-two 
mothers in the term group and twenty-two mothers in preterm group. Preterm and term groups at 
baseline did not differ in maternal age, marital status, maternal BMI, public assistance, previous 
pregnancy, or smoking history.  However, significant differences were observed regarding 
maternal race, with 62% of Caucasian mothers in the term group and 73% of African American 
mothers in the preterm group (Table 1). With regard to ante-partum clinical measures, both 
groups had similar mean gingival index (GI), plaque index (PI), bleeding on probing (BOP), 
extent of sites with probing depth (PD) at least 4mm, and attachment level (AL) at least 3mm. In 
terms of postpartum clinical measures, no differences were observed between groups (Table 1). 
Maternal Subgingival Plaque Samples Microbial Profile 
 Pre-partum subgingival plaque samples show high abundance of oral commensal species, 
such as Actinomyces gerencseriae (FTB: 8.3% ± 6.4%, PTB: 6.2% ± 5.4%, p= 0.24), 
Actinomyces israelli (FTB: 6.5% ± 3.9%, PTB: 5.8% ± 5.3%, p= 0.30), Actinomyces oris (FTB: 
6.2% ± 5.6%, PTB: 6.1% ± 4.8%, p= 0.90), and Actinomyces naeslundii (FTB: 6.1% ± 5.3%, 
PTB: 4.6% ± 3.3%, p=0.39). Statistically significant differences between FTB and PTB samples 
were observed for Aggregatibacter actinomycetemcomitans (FTB: 1.0% ± 0.7%, PTB: 1.6 ± 
0.9%, p= 0.02), Campylobacter gracilis (FTB: 1.8% ± 1.1%, PTB: 2.4 ± 1.0, p= 0.01), 
Fusobacterium nucleatum ss vicentii (FTB: 2.3% ± 1.5%, PTB: 3.4% ± 1.8%, p= 0.05), 
Veillonella parvula (FTB: 1.9% ± 3.4%, PTB: 3.4% ± 3.3%, p= 0.00), and Treponema socranskii 
(FTB: 2.3% ± 1.5 %, PTB: 3.7% ± 1.8%, p= 0.01). Periodontal pathogens of the red complex, 
(P. gingivalis, T. forsythia, and T. denticola) were also detected (Fig. 1). 
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When comparing pre-partum and post-partum changes in mean percentages of DNA 
count of subgingival plaque samples, increased in commensal organisms such as A. oris, A. 
naeslundii, A. israelii, and A. gerencseriae were observed in samples from PTB. However, 
increases in periodontal pathogens T. denticola, P. gingivalis, and T. forsythia were observed in 
subgingival plaque samples from PTB (Fig. 2). 
Correlation between Ante-partum Subgingival Plaque Profile and Clinical measurements 
 Positive correlations were observed between presence of P. gingivalis in ante-partum 
subgingival plaque samples and the following clinical measurements: extent of AL ≥ 3mm (CC: 
0.366, p=0.05), BOP (CC: 0.375, p= 0.04), and GI (CC:0.68, p= 0.00). F. nucleatum ss 
nucleatum showed positive correlations for GI (CC: 0.368, p= 0.05) only. Commensal oral 
microorganisms such as Streptococcus oralis showed negative correlations for extent of AL ≥ 
3mm (CC: -0.414, p= 0.02) and GI (CC: -0.359, p= 0.05). While, V. parvula (CC: -0.376, p= 
0.04) and Streptococcus sanguinis (CC: -0.359, p= 0.05) showed negative correlations for GI 
(Table 3). 
Microbial Profile of FTB/PTB placenta samples 
 Sequencing of placenta samples revealed 8 different phyla, 84 genera, and 132 species. 
While, umbilicus samples revealed 8 different phyla, 100 genera, and 225 species. Most 
abundant species in placenta samples were: Neisseria elongata (FTB: 4.78% ± 4.95%, PTG: 
3.84% ± 4.51%, p= 0.53), Gemella morbillorum (FTB: 3.21% ± 4.80%, PTB: 3.98% ± 5.09%, 
p= 0.45), Streptococcus constellatus (FTB: 3.99% ± 4.44%, PTB: 3.16% ± 3.68%, p= 0.52), and 
Anaeroglobus geminatus (FTB: 2.39% ± 3.28, PTB: 3.19% ± 4.84%, p: 0.66) (Fig. 3). Several 
periodontal microorganisms were detected in placental samples: Fretibacterium fastidiosum, , 
Campylobacter gracilis, Parvimonas micra, Capnocytophaga gingivalis, Prevotella nigrescens, 
Eikenella corrodens, and Treponema denticola,  However, no statistically significant differences 
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were observed between groups. Key periodontal pathogens such as Aggregatibacter 
actinomycetemcomitans, Porphyromonas gingivalis, and Tanerella forsythia were not detected. 
Microbial Profile of FTB/PTB umbilicus samples 
 The most abundant species in umbilicus samples were: Pyramidobacter_piscolens (FTB: 
6.1% ± 11.8%, PTB: 6.3% ± 14.5%, p= 0.64),  Gemella morbillorum (FTB: 1.5% ± 1.7%, PTB: 
1.8% ± 2.5%, p= 0.98),  Streptococcus constellatus (FTB: 1.8% ± 2.0%, PTB: 1.7% ± 2.2%, 
p=0.79), and Neisseria elongata (FTB: 1.5% ± 2.3%, PTB: 1.6 % ± 3.0%, p= 0.93) (Fig 4). The 
following species were found to be statistically significant different between groups:  
Granulicatella adiacens (FTB: 0.2% ± 0.6%, PTB: 1.2% ± 1.5%, p= 0.01), Anaeroglobus 
geminatus (FTB: 2.1% ± 2.7%, PTB: 0.5% ± 0.9%, p= 0.03), Lactobacillus iners (FTB: 2.3% ± 
6.7%, PTB: 0.5% ± 2.2%, p= 0.02), Peptostreptococcaceae [XI] [G-7] HOT 081 (FTB: 0.0 ± 
0.1, PTB: 0.4 ± 1.1; p: 0.02), and Eubacterium nodatum (FTB: 0.0 ± 0.1, PTB: 0.4 ± 0.7; p= 
0.04). Several periodontal microorganisms were detected in umbilical samples: Campylobacter 
gracilis, Fretibacterium fastidiosum, Fusobacterium HOT 204,  Parvimonas micra, 
Porphyromonas gingivalis, Prevotella intermedia,  Prevotella nigrescens, and Treponema 
denticola. Key periodontal pathogens such as A. actinomycetemcomitans and T. forsythia were 
not detected. 
Correlation between Placenta Samples Microbial Profile and Clinical Measurements 
 Positive correlations were observed between presence of C. tuscaniense in placenta 
samples and extent of AL ≥3mm (CC: 0.495, p = 0.001), extent of PD ≥4mm (CC: 0.302 , p= 
0.046), GI (CC: 0.405, p=0.006), and PI (CC: 0.422, p=0.0064. Leptotrichia HOT 223 showed 
positive correlations for extent of AL ≥3mm (CC: 0.495, p = 0.001), extent of PD ≥4mm (CC: 
0.302 , p= 0.046), GI (CC: 0.405, p=0.006), and PI (CC: 0.422, p=0.0064. While, Fusobacterium 
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HOT 204 showed positive correlations for extent of AL ≥ 3mm (CC: 0.389, p = 0.009), GI (CC: 
0.344, p=0.022), and PI (CC: 0.386, p=0.010). 
Correlation between Umbilicus Samples Microbial Profile and Clinical Measurements 
 Positive correlations were found between presence of P.gingivalis in umbilical tissues 
and extent of AL ≥ 3mm (CC: 0.482, p = 0.001), GI (CC: 0.365, p=0.015), and PI (CC: 0.408, 
p=0.006). While, presence of  TM7 [G1] HOT 347 in umbilical tissues showed positive 
correlations with extent of AL ≥ 3mm (CC: 0.439, p=0.003), extent of PD ≥ 4mm (CC: 0.388, 
p=0.009), GI (CC: 0.398, p=0.008), and GI (CC:0.378, p= 0.011). Presence of  P. loescheii in 
umbilical tissues showed a positive correlation with GI (CC: 0.383, p=0.01) and PI (CC: 0.42, p= 
0.005) (Table 3).  
Correlation between Ante-partum Subgingival Plaque and Microbiome of Placental and 
Umbilical Tissues 
 
Presence of the following periodontal pathogens in subgingival plaque showed positive 
correlations to periodontal microorganisms found in placenta samples. P.gingivalis showed a 
positive correlation to presence of C. tuscaniense (CC 0.648, p < 0001),   Fusobacterium HOT 
204 (CC 0.581, p <0.001), and Leptotrichia HOT 223 (CC 0.648, p .0001). F. nucleatum ss 
vicentii with Mycoplasma hominis (CC 0.672, p<0.0001), Peptostreptococcus stomatis (CC 
0.691, p<0.0001), and Pseudoramibacter alactolyticus (CC 0.679, p<0.0001). T. socranskii with 
Dialister invisus (CC 0.594, p<0.0001). T. denticola with C. gracilis (CC 0.609, p <0.0001) and 
Rothia aeria (CC 0.590, p<0.0001). P. nigrescens with Bifidobacterium dentium (CC 0.737, p 
<0.0001), and Campylobacter curvus (CC 0.714, p <0.0001). 
 Presence of the following periodontal pathogens in subgingival plaque showed positive 
correlations to periodontal microorganisms found in umbilicus samples. P.gingivalis in 
subgingival plaque samples showed a positive correlation to presence of Campylobacter 
61  
tuscaniense (Correlation Coefficient [CC], p value) (0.62505, p <.0001), Peptoniphilus 
lacrimalis (CC 0.682, p <.0001), & Prevotella loeschii (CC 0.062733, p <.0001). F. nucleatum 
ss vicentii showed a positive correlation to presence of Abiotrophia defectiva (CC 0.679, p <0), 
Actinomyces johnsonii (CC 0.642, p <.0001), Capnocytophaga leadbetteri (CC 0.654, p <.0001), 
Kingella oralis ( CC 0.679, p <.0001), Leptotrichia HOT 392 (CC 0.679, p<.0001),  and 
Mycoplasma hominis (CC 0.679, p<.0001) . Parvimonas micra with S. Sanguinis (0.603, 
p<.0001). T. denticola with Lactococcus lactis (CC 0.602, p <.0001) and Selenomonas noxia 
(CC 0.613, p <.0001). F. nucleatum ss nucleatum with Corynebacterium Matruchotii (CC 0.575, 
p <.0001) and Peptoniphilus lacrimalis (CC 0.590, p<.0001). P. intermedia with Bifidobacterium 
breve (CC 0.627, p<.0001), Leptotrichia  HOT 221 (CC 0.742, p <.0001), and 
Peptostreptococcaceae [XI] [G7] [Eubacterium] _yurii_subsp_yurii_&_margaretiae  (CC 
0.717, p <.0001) (Fig. 5). 
DISCUSSION 
The pathogenesis of PTB seems to be complex and multifactorial, however, infection of 
the intrauterine cavity seems to be one of the leading causes.12,31,18 The effect of preterm birth 
amongs some survivors may continue throughout life, impairing neuro-developmental 
functioning through increasing the risk of cerebral palsy, learning impairment and visual 
disorders and affecting long-term physical health with a higher risk of non-communicable 
disease.33  
Several studies have demonstrated an association between periodontal disease and PTB, 
however, the actual mechanisms have yet to be determined.21,23,25,27,29,40 In a case-control study 
by Offenbacher and colleagues periodontal disease was shown to be a statistically significant risk 
factor for  preterm low birth weight (PLBW) with odd ratios of 7.9  for all PLBW cases.28 A 5-
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year prospective study in pregnant women, found periodontal disease incidence and progression 
to be significantly associated with low weight for gestational age, as well as, increased relative 
risk for PTB and very PTB. Severity of maternal periodontal disease was also shown to be a 
predictor of more severe APOs.26,29 A meta-analysis by Vergnes and colleagues, concluded that 
periodontal disease may be an independent risk factor for preterm low birth weight, with odds 
ratio of 2.83.40 Higher  prevalence of IgM seropositivity for one or more organisms of the 
Orange or Red complex was shown among preterm babies Reduced maternal IgG antibody to 
periodontal pathogens of the Red complex has been associated with an increased rate of PTB 
with odds ratio (OR) = 2.2.21 
Oral microorganisms have been shown to have the ability to translocate into the 
intrauterine cavity via hematogenous dissemination. In a pregnant murine model, intravenous 
injection of F. nucleatum resulted in premature delivery, nonsustained live births, and 
stillbirths.15 F. nucleatum has been shown to have the ability to  adhere and invade epithelial and 
endothelial cells via novel FadA adhesion, in mixed infections, F. nucleatum could facilitate the 
hematogenous spread of other microorganisms.10 Bergeyella has been detected cases of PTB 
with intrauterine infection, were the same strain of Bergeyella was detected in the subgingival 
plaque of the mother but not in the vaginal tract.14  
We were able to demonstrate the presence of multiple oral microorganisms in both 
placental and umbilical tissues. Our samples showed presence of several genera found in the oral 
cavity, which have been shown to have the ability to translocate to the placenta in a murine 
model, such as, Veillonella, Streptococcus, Porphyromonas, Parvimonas, Prevotella, Neisseria, 
Leptotrichia, and Bacteroidetes.9 Furthermore, we were able to detect genera of microorganisms 
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associated with PTB: Leptotrichia, Neisseria, Peptostreptococcus, Streptococcus, 
Veillonella.6,16,35 
Our samples demonstrated presence of oral species previously implicated in extra-oral 
infections, inflammation, and APOs: E. corrodens, P. gingivalis, P. nigrescens, and T. 
denticola.17 Detected species such as G. morbillorum, E. corrodens, and Porphyromonas 
endodontalis have been shown to have the ability to hematogenously disseminate and colonize 
the placenta in an animal model.9 In our study,  we were able to detect several oral species in 
both fetal tissues and maternal subgingival plaque, such as, E. nodatum, E. corrodens, F. 
fastidiosum, G. morbillorum, P. gingivalis, P. micra, S. constellatus, S. anginosus, and T. 
denticola. The co-occurrence of these species could explain the origin of these bacteria found in 
the fetal tissues.  
Our subgingival plaque samples from FTB and PTB showed similar levels of periodontal 
pathogens of the red complex: P. gingivalis, T. denticola, and T. forsythia. However, PTB 
subgingival plaque samples harbored higher levels of  A. actinomycetemcomitans, T. socranskii, 
and pathogens of the orange complex, such as, F. nucleatum ss nucleatum and C. gracilis. 
Interestingly, plaques samples of PTB subjects showed increased levels of F. nucleatum, P. 
intermedia,  P. gingivalis, T. denticola, and T.forsythia immediately after delivery. Subgingival 
plaque presence of  P. gingivalis and F. nucleatum ss nucleatum was positively correlated with 
clinical parameters, while presence of commensal organisms, S. oralis, S. sanguinis, and F. 
nucleatum ss vicentii were negatively correlated.  
In the umbilicus microbiome E. nodatum, a periodontal pathogen of the orange complex 
showed statistically higher levels in PTB samples, while the vaginal commensal organism L. 
iners was statistically higher in FTB. The presence of P. gingivalis in umbilical tissues was 
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associated with mothers presenting more severe periodontal disease. The presence of P. 
gingivalis in subgingival plaque samples was not associated with the presence of P. gingivalis in 
umbilical tissues, this negative correlation could be due to the different methods used to analyze 
each sample type. Furthermore, taxa not detected in our samples does not  necessarily indicate 
those microorganisms are not able to translocate to the fetal tissues, perhaps our methods for 
sample collection and analyses did not allow for their detection. C. rectus is an orange complex 
periodontal pathogen, which has been previously proposed as a primary fetal infectious agent 
that could have the ability to elicit PTB.21 We were not able to detect C. rectus in our samples 
due to its probe not being included as part of the HOMINGS sequencing database. Future 
directions could include oligotyping and OTU level analysis of the microbiomes to improve taxa 
identification. 
There are limitations in the present study. The first one is its sample size. This was a pilot 
study, therefore, we were not able to performed power calculations.  Also, we were limited by 
the amount of available samples from subjects that met all the criteria for our study. A second 
limitation of the present study is its cross sectional design, which precludes any inference on a 
causal role of the microbiome in PTB. A third limitation, was that the plaque samples available 
for analysis did not allow for DNA extraction and 16S rRNA sequencing due to being stored in 
sodium hydroxide. This limited the possibility of detecting a larger number of species, than the 
41 species included in checkerboard DNA-DNA hybridization method.   
CONCLUSIONS 
Mothers who experienced PTB harbored greater levels of pathogenic taxa in their 
subgingival biofilms at baseline and after delivery. Common oral bacteria were detected in 
placental and umbilical tissues, as well as, maternal subgingival plaque, suggesting the source of 
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these bacteria may be the oral cavity. The presence of P. gingivalis in the umbilical microbiome 
was positively correlated with periodontal parameters.   
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Table 1:  Demographics and Periodontal Parameters of Study Population  
 
Term Preterm p(value
Maternal/Race
!!African!American 4!(27%) 11!(73%)
!!Caucasian 18!(62%) 11!(38%) 0.03
Mean/(SD)
Maternal/Age 25.2!(3.6) 25.7!(6.7) 0.74
Mean/(SD)/Pre/Pregnancy
BMI 26.5!(4.5) 27.9!(5.3) 0.36
Married 11!(55%) 9!(45%)
!!Not!Married 11!(46%) 13!(54%) 0.54
WIC 18!(51%) 17!(49%)
!!No 4!(44%) 5!(56%) 0.71
Nulliparous 4!(36%) 7!(64%)
!!No 18!(55%) 15!(46%) 0.3
Smoking/During/Pregnancy 3!(60%) 2!(40%)
!!No 19!(49%) 20!(51%) 0.63
Mean/(SD)
Extent/AL/>=3mm 18.5!(9.6) 19.0!(12.3) 0.9
Mean/(SD)
Extent/PD/>=4mm 26.3!(14.7) 24.3!(19.1) 0.69
Mean(SD)//BOP 47.7!(29.4) 44.0!(31.7) 0.66
Mean/(SD)/GI 1.3!(0.4) 1.2!(0.5) 0.26
Mean/(SD)/PI 2.9!(0.5) 2.8!(0.6) 0.56
Mean/(SD)
Extent/AL/>=3mm 12.9!(14.4) 10.7!(13.0) 0.61
Mean/(SD)
Extent/PD/>=4mm 27.6!(19.1) 22.1!(19.8) 0.37
Mean/(SD)/BOP 42.7!(28.1) 26.1!(25.4) 0.06
Mean/(SD)/GI 1.1!(0.4) 0.9!(0.4) 0.13
Mean/(SD)/PI 3.0!(0.5) 2.8!(0.6) 0.36
Ante/Partum/Clinical/Measures
Post/Partum/Clinical/Measures
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Table	  2:	  Correlations	  between	  Baseline	  Clinical	  Parameters	  and	  Oral	  Microbiome	  
 
Oral%Species
Coefficient p"value Coefficient p"value Coefficient p"value Coefficient p"value
P.%gingivalis 0.366 0.05 0.375 0.04 0.638 0
F.%nucleatum%ss%vincentii 00.425 0.02 00.426 0.02
V.%parvula 00.416 0.02 00.376 0.04
S.%sanguinis 00.404 0.03
S.%oralis 00.414 0.02 00.359 0.05
F.%nucleatum%ss%nucleatum 0.368 0.05
P.%melaninogenica 00.391 0.03
Extent+AL+>=+3mm+
(nal_3/npdsites)
Extent+PD+>=+4mm+
(npd_4/npdsites)
Extent+BOP+(nbl/nblsites) Average+Gingival+Index
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Table	  3:	  Correlations	  between	  Baseline	  Clinical	  Parameters	  and	  Umbilicus	  Microbiome	  
 
    
Oral%Species
Coefficient p"value Coefficient p"value Coefficient p"value Coefficient p"value Coefficient p"value
Actinomyces_sp_HOT_175 0.362 0.016
Atopobium_parvulum 0.307 0.042
Bacteroidales[GA2]_sp_HOT_274 00.313 0.038
Bifidobacterium_longum 0.314 0.038
Gemella_morbillorum 0.310 0.041
Gemella_morbillorum
Gemella_morbillorum 0.306 0.043
Lactococcus_lactis 0.456 0.002
Mitsuokella_multacida 0.431 0.004
Peptoniphilus_lacrimalis 0.484 0.001 0.331 0.028 0.419 0.005 0.410 0.006
Porphyromonas_gingivalis 0.482 0.001 0.365 0.015 0.408 0.006
Prevotella_loescheii 0.519 0.000 0.320 0.034 0.383 0.010 0.420 0.005
Prevotella_nigrescens 00.377 0.012
Prevotella_oralis 00.370 0.014
Ruminococcaceae[GA3]_sp_HOT_381 0.431 0.004
Selenomonas_noxia 0.459 0.002
Stenotrophomonas_maltophilia 0.408 0.006
Streptococcus_sobrinus 00.327 0.030
TM7[GA1]_sp_HOT_347 0.439 0.003 0.388 0.009 0.398 0.008 0.378 0.011
Extent%AL%>=%3mm%
(nal_3/npdsites)
Extent%PD%>=%4mm%
(npd_4/npdsites)
Extent%BOP%(nbl/nblsites) Average%Gingival%Index Average%Plaque%Score
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Figure 1:  Pre-partum Mean ( %) DNA Probe Count (±	  SD) of Subgingival Biofilm Samples  
(FTB: blue, PTB: red). ^p=0.01, ^^p=0.02, *p=0.03, **p=0.04 (Differences did not reach FDR-
adjusted statistical significance). 
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Figure 2:  Pre-partum and Post-partum Changes in Mean (%) DNA Probe Count (±	  SD) of  
Subgingival Biofilm Samples (FTB: blue, PTB: red). ^p=0.01, ^^p=0.02, *p=0.03, **p=0.04 
(Differences did not reach FDR-adjusted statistical significance).  
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Figure 3:  Mean relative abundance ( % ±	  SD) of the most prevalent species detected in 
placenta samples  (FTB: blue, PTB: red). ^p=0.01, ^^p=0.02, *p=0.03, **p=0.04 (Differences 
did not reach FDR-adjusted statistical significance).  
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Figure 4:  Mean relative abundance ( % ±	  SD) of the most prevalent species detected in 
umbilicus samples  (FTB: blue, PTB: red). ^p=0.01, ^^p=0.02, *p=0.03, **p=0.04 (Differences 
did not reach FDR-adjusted statistical significance).  
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Figure 5:  Correlation between Pre-term Oral and Umbilical Microbiomes  (p<0.0001)
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